Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume $0.32 +0.02 (+6.63%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Petros Pharmaceuticals Short Interest DataPetros Pharmaceuticals (PTPI) has a short interest of 646,200 shares, representing 7.08% of the float (the number of shares available for trading by the public). This marks a 139.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 1.95 million shares to cover all short positions.Current Short Interest646,200 sharesPrevious Short Interest269,700 sharesChange Vs. Previous Month+139.60%Dollar Volume Sold Short$254,538.18Short Interest Ratio0.3 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares10,020,000 sharesFloat Size9,130,000 sharesShort Percent of Float7.08%Today's Trading Volume210,982 sharesAverage Trading Volume1,945,098 sharesToday's Volume Vs. Average11% Short Selling Petros Pharmaceuticals? Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTPI Short Interest Over TimePTPI Days to Cover Over TimePTPI Percentage of Float Shorted Over Time Petros Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024646,200 shares $254,538.18 +139.6%7.1%0.3 $0.39 12/15/2024269,700 shares $88,947.06 +48.9%3.0%0.2 $0.33 11/30/2024181,100 shares $49,693.84 -9.7%2.0%0.9 $0.27 11/15/2024200,600 shares $51,955.40 +0.7%2.2%1.1 $0.26 10/31/2024199,200 shares $73,704.00 -27.2%2.2%1.2 $0.37 10/15/2024273,600 shares $83,393.28 -7.2%3.1%1.4 $0.30 9/30/2024294,900 shares $105,279.30 +25.4%3.4%1.3 $0.36 9/15/2024235,100 shares $85,650.93 -20.6%2.7%0.8 $0.36 8/31/2024295,900 shares $98,445.93 +13.5%3.5%0.8 $0.33 8/15/2024260,700 shares $86,969.52 -40.0%3.1%0.6 $0.33 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024434,200 shares $176,285.20 +69.9%7.1%1 $0.41 7/15/2024255,500 shares $115,997.00 -28.5%4.2%0.6 $0.45 6/30/2024357,200 shares $163,419.00 -23.7%5.8%1 $0.46 6/15/2024468,300 shares $194,578.65 +202.3%7.7%1 $0.42 5/31/2024154,900 shares $95,139.58 +82.9%2.5%0.3 $0.61 5/15/202484,700 shares $43,671.32 -37.0%1.4%0.1 $0.52 4/30/2024134,500 shares $88,299.25 +92.7%3.3%0.2 $0.66 4/15/202469,800 shares $54,660.38 -52.3%1.7%0.1 $0.78 3/31/2024146,200 shares $216,376.00 +65.4%3.6%0.1 $1.48 3/15/202488,400 shares $134,368.00 -72.1%6.8%0.1 $1.52 2/29/2024317,200 shares $545,584.00 +12.3%24.2%0.3 $1.72 2/15/2024282,400 shares $434,896.00 +16.5%21.9%0.3 $1.54 1/31/2024242,400 shares $293,304.00 +2,208.6%18.8%0.4 $1.21 1/15/202410,500 shares $13,807.50 -74.8%0.8%0 $1.32 12/31/202341,700 shares $58,797.00 -66.5%3.1%0.2 $1.41 12/15/2023124,300 shares $172,777.00 +571.9%9.1%0.6 $1.39 11/30/202318,500 shares $29,600.00 -28.3%1.4%0.2 $1.60 11/15/202325,800 shares $34,314.00 -41.6%2.0%0.8 $1.33 10/31/202344,200 shares $63,206.00 -27.9%3.5%1.3 $1.43 10/15/202361,300 shares $98,073.87 +415.1%4.9%1.4 $1.60 9/30/202311,900 shares $20,585.81 +213.2%0.9%0 $1.73 9/15/20233,800 shares $6,878.00 -82.3%0.3%0 $1.81 8/31/202321,500 shares $54,825.00 -62.7%1.7%0.1 $2.55 8/15/202357,700 shares $184,640.00 -21.9%3.9%0.2 $3.20 7/31/202373,900 shares $296,339.00 -79.4%5.0%0.2 $4.01 7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19 6/30/202325,100 shares $50,953.00 -27.0%1.7%0 $2.03 6/15/202334,400 shares $89,784.00 -10.7%2.3%0 $2.61 5/31/202338,500 shares $89,705.00 -13.5%2.6%0 $2.33 5/15/202344,500 shares $186,900.00 -88.5%3.0%0 $4.20Do this Before Elon’s Reveal on January 29th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30 4/15/202334,100 shares $156,519.00 -22.5%2.4%0 $4.59 3/31/202344,000 shares $61,380.00 +14.9%3.1%3.1 $1.40 3/15/202338,300 shares $56,684.00 +13.0%2.7%2.1 $1.48 2/28/202333,900 shares $71,190.00 -6.6%2.4%1.6 $2.10 2/15/202336,300 shares $92,202.00 +23.1%2.5%1.8 $2.54 1/31/202329,500 shares $76,700.00 -24.4%2.1%1.5 $2.60 1/15/202339,000 shares $118,950.00 +14.0%2.7%1.6 $3.05 12/30/202234,200 shares $79,686.00 +14.8%2.4%1.4 $2.33 12/15/202229,800 shares $63,176.00 +43.3%2.1%1.8 $2.12 11/30/202220,800 shares $8,550.88 -92.2%1.4%1.5 $0.41 11/15/2022265,700 shares $130,193.00 +78.6%N/A2.1 $0.49 10/31/2022148,800 shares $71,424.00 +9.3%N/A1 $0.48 10/15/2022136,200 shares $58,525.14 +77.3%N/A0.2 $0.43 9/30/202276,800 shares $39,168.00 -36.1%N/A0.1 $0.51 9/15/2022120,200 shares $78,682.92 -7.1%N/A0.1 $0.65 8/31/2022129,400 shares $84,821.70 +45.4%N/A0.1 $0.66 8/15/202289,000 shares $71,627.20 +420.5%N/A0.1 $0.80 7/31/202217,100 shares $13,573.98 -22.3%N/A0 $0.79 7/15/202222,000 shares $18,099.40 -56.2%N/A0.1 $0.82 6/30/202250,200 shares $42,157.96 +46.8%N/A0 $0.84 6/15/202234,200 shares $26,744.40 -81.0%N/A0 $0.78 5/31/2022179,500 shares $174,976.60 +89.2%N/A0.1 $0.97 5/15/202294,900 shares $91,113.49 -30.0%N/A0.1 $0.96 4/30/2022135,600 shares $153,228.00 -26.0%N/A0.1 $1.13 4/15/2022183,300 shares $221,793.00 -39.8%N/A0.1 $1.21 3/31/2022304,400 shares $474,864.00 +15.1%N/A0.4 $1.56 3/15/2022264,500 shares $285,660.00 -39.7%N/A0.1 $1.08 2/28/2022438,900 shares $605,682.00 -38.5%N/A0.1 $1.38 2/15/2022714,000 shares $1.14 million -15.3%N/A0.1 $1.59 1/31/2022842,700 shares $1.46 million -54.9%N/A0.1 $1.73 1/15/20221,870,000 shares $4.90 million -19.7%N/A0.1 $2.62 12/31/20212,330,000 shares $7.76 million -22.9%28.1%0.1 $3.33 12/15/20213,020,000 shares $8.67 million +41.1%35.7%0.2 $2.87 11/30/20212,140,000 shares $6.12 million +459.6%55.9%0.2 $2.86 11/15/2021382,400 shares $833,632.00 +359.6%8.9%0.1 $2.18 10/29/202183,200 shares $144,768.00 -22.2%2.6%0 $1.74 10/15/2021106,900 shares $175,316.00 +20.0%1.8%1.2 $1.64 9/30/202189,100 shares $178,200.00 -22.9%1.5%1.6 $2.00 9/15/2021115,600 shares $239,292.00 -20.8%1.9%2.1 $2.07 8/31/2021145,900 shares $328,275.00 -16.1%2.4%1.8 $2.25 8/13/2021173,900 shares $525,178.00 -9.1%2.8%1.7 $3.02 7/30/2021191,200 shares $581,248.00 +19.3%3.1%0.9 $3.04 7/15/2021160,300 shares $488,915.00 +18.3%2.6%0.8 $3.05 6/30/2021135,500 shares $424,115.00 +21.1%2.2%0.7 $3.13 6/15/2021111,900 shares $349,128.00 +105.0%1.8%0.5 $3.12 5/28/202154,600 shares $165,438.00 -1.1%0.9%0.3 $3.03 5/14/202155,200 shares $162,840.00 -18.9%0.9%0.3 $2.95 4/30/202168,100 shares $224,730.00 +6.2%1.1%1.4 $3.30 4/15/202164,100 shares $201,915.00 -19.0%1.0%0.8 $3.15Do this Before Elon’s Reveal on January 29th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 3/31/202179,100 shares $288,715.00 +4.2%1.3%0.9 $3.65 3/15/202175,900 shares $256,542.00 +20.5%1.2%0.5 $3.38 2/26/202163,000 shares $218,610.00 -9.1%1.0%0.4 $3.47 2/12/202169,300 shares $293,832.00 +234.8%1.1%0.4 $4.24 1/29/202120,700 shares $70,173.00 +269.6%0.3%0.1 $3.39 1/15/20215,600 shares $24,136.00 No ChangeN/A0 $4.31 PTPI Short Interest - Frequently Asked Questions What is Petros Pharmaceuticals' current short interest? Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 646,200 shares of PTPI short. 7.08% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest. What is a good short interest percentage for Petros Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.08% of Petros Pharmaceuticals' floating shares are currently sold short. Is Petros Pharmaceuticals' short interest increasing or decreasing? Petros Pharmaceuticals saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 646,200 shares, an increase of 139.6% from the previous total of 269,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Petros Pharmaceuticals' float size? Petros Pharmaceuticals currently has issued a total of 10,020,000 shares. Some of Petros Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Petros Pharmaceuticals currently has a public float of 9,130,000 shares. How does Petros Pharmaceuticals' short interest compare to its competitors? 7.08% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Petros Pharmaceuticals: Imunon, Inc. (7.04%), HCW Biologics Inc. (0.66%), Sensei Biotherapeutics, Inc. (0.66%), Flora Growth Corp. (7.61%), Bright Green Co. (0.89%), Hoth Therapeutics, Inc. (9.26%), CervoMed Inc. (23.55%), ANEW Medical, Inc. (1.67%), Relmada Therapeutics, Inc. (5.47%), TherapeuticsMD, Inc. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Petros Pharmaceuticals stock? Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Petros Pharmaceuticals? A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further. How often is Petros Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Imunon Short Squeeze HCW Biologics Short Squeeze Sensei Biotherapeutics Short Squeeze Flora Growth Short Squeeze Bright Green Short Squeeze Hoth Therapeutics Short Squeeze CervoMed Short Squeeze ANEW Medical Short Squeeze Relmada Therapeutics Short Squeeze TherapeuticsMD Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTPI) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTPI Stock Alerts